Imagin Medical Inc. (IMEXF)
USD 0.0
(-99.09%)
USD 0.0
(-99.09%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -3.4 Million CAD | 8.91% |
| 2021 | -3.84 Million CAD | 11.27% |
| 2020 | -4.33 Million CAD | 2.67% |
| 2019 | -4.45 Million CAD | 44.16% |
| 2018 | -7.97 Million CAD | -425.85% |
| 2017 | -1.46 Million CAD | 18.47% |
| 2016 | -1.81 Million CAD | -362.6% |
| 2015 | -98.11 Thousand CAD | 25.81% |
| 2014 | -541.68 Thousand CAD | -0.42% |
| 2013 | -539.41 Thousand CAD | 12.01% |
| 2012 | -613.01 Thousand CAD | 35.87% |
| 2011 | -955.95 Thousand CAD | -66.63% |
| 2010 | -573.71 Thousand CAD | 6.59% |
| 2009 | -614.22 Thousand CAD | -124.37% |
| 2008 | 2.52 Million CAD | 214.83% |
| 2007 | -2.19 Million CAD | -59.29% |
| 2006 | -1.37 Million CAD | -72.2% |
| 2005 | -800.27 Thousand CAD | -502.27% |
| 2004 | -133.52 Thousand CAD | -158.75% |
| 2003 | -146.51 Thousand CAD | 236.12% |
| 2002 | -166.16 Thousand CAD | -5.86% |
| 2001 | -156.96 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q3 | -292.82 Thousand CAD | 64.52% |
| 2023 Q2 | -825.23 Thousand CAD | -32.49% |
| 2023 Q1 | -622.88 Thousand CAD | 42.02% |
| 2022 Q1 | -772.23 Thousand CAD | 42.01% |
| 2022 FY | - CAD | 8.91% |
| 2022 Q4 | -1.07 Million CAD | -24.16% |
| 2022 Q3 | -865.3 Thousand CAD | -9.53% |
| 2022 Q2 | -789.98 Thousand CAD | -2.3% |
| 2021 Q2 | -890.04 Thousand CAD | -36.66% |
| 2021 Q1 | -651.3 Thousand CAD | 2.97% |
| 2021 FY | - CAD | 11.27% |
| 2021 Q4 | -1.33 Million CAD | -37.78% |
| 2021 Q3 | -966.6 Thousand CAD | -8.6% |
| 2020 Q4 | -671.22 Thousand CAD | -17.27% |
| 2020 FY | - CAD | 2.67% |
| 2020 Q1 | -1.23 Million CAD | 6.47% |
| 2020 Q2 | -1.85 Million CAD | -51.04% |
| 2020 Q3 | -572.38 Thousand CAD | 69.2% |
| 2019 Q1 | -1 Million CAD | 54.44% |
| 2019 FY | - CAD | 44.16% |
| 2019 Q4 | -1.31 Million CAD | -11.55% |
| 2019 Q3 | -1.17 Million CAD | -24.69% |
| 2019 Q2 | -945.82 Thousand CAD | 5.84% |
| 2018 Q4 | -2.2 Million CAD | -25.01% |
| 2018 Q3 | -1.76 Million CAD | 35.24% |
| 2018 FY | - CAD | -425.85% |
| 2018 Q2 | -2.72 Million CAD | -112.8% |
| 2018 Q1 | -1.27 Million CAD | -251.88% |
| 2017 Q3 | -293.94 Thousand CAD | 22.2% |
| 2017 FY | - CAD | 18.47% |
| 2017 Q4 | -363.71 Thousand CAD | -23.74% |
| 2017 Q2 | -377.8 Thousand CAD | 21.36% |
| 2017 Q1 | -480.4 Thousand CAD | 24.77% |
| 2016 Q1 | -139.25 Thousand CAD | -23.14% |
| 2016 FY | - CAD | -362.6% |
| 2016 Q4 | -638.59 Thousand CAD | 0.39% |
| 2016 Q3 | -641.08 Thousand CAD | -20.46% |
| 2016 Q2 | -532.18 Thousand CAD | -282.16% |
| 2015 Q2 | -100.39 Thousand CAD | 4.67% |
| 2015 Q4 | -113.08 Thousand CAD | -36.07% |
| 2015 Q3 | -83.1 Thousand CAD | 17.21% |
| 2015 FY | - CAD | 25.81% |
| 2015 Q1 | -105.31 Thousand CAD | 17.78% |
| 2014 Q1 | -89.38 Thousand CAD | 31.8% |
| 2014 FY | - CAD | -0.42% |
| 2014 Q2 | -97.85 Thousand CAD | -9.47% |
| 2014 Q4 | -128.08 Thousand CAD | 43.42% |
| 2014 Q3 | -226.36 Thousand CAD | -131.33% |
| 2013 Q1 | -137.21 Thousand CAD | 3.53% |
| 2013 FY | - CAD | 12.01% |
| 2013 Q4 | -131.06 Thousand CAD | 9.91% |
| 2013 Q3 | -145.48 Thousand CAD | -15.77% |
| 2013 Q2 | -125.66 Thousand CAD | 8.42% |
| 2012 Q4 | -142.23 Thousand CAD | 19.53% |
| 2012 Q3 | -176.76 Thousand CAD | 2.55% |
| 2012 FY | - CAD | 35.87% |
| 2012 Q2 | -181.4 Thousand CAD | -61.1% |
| 2012 Q1 | -112.6 Thousand CAD | 25.88% |
| 2011 Q3 | -564.97 Thousand CAD | -351.73% |
| 2011 FY | - CAD | -66.63% |
| 2011 Q4 | -151.93 Thousand CAD | 73.11% |
| 2011 Q1 | -113.98 Thousand CAD | 87.22% |
| 2011 Q2 | -125.06 Thousand CAD | -9.72% |
| 2010 Q2 | -79.1 Thousand CAD | -225.57% |
| 2010 Q3 | 338.16 Thousand CAD | 527.49% |
| 2010 Q4 | -892.11 Thousand CAD | -363.81% |
| 2010 Q1 | 62.99 Thousand CAD | 132.09% |
| 2010 FY | - CAD | 6.59% |
| 2009 FY | - CAD | -124.37% |
| 2009 Q4 | -196.31 Thousand CAD | -41.93% |
| 2009 Q3 | -138.32 Thousand CAD | 7.19% |
| 2009 Q1 | 370.26 Thousand CAD | 245.8% |
| 2009 Q2 | -149.03 Thousand CAD | -140.25% |
| 2008 Q2 | 801.57 Thousand CAD | 321.16% |
| 2008 FY | - CAD | 214.83% |
| 2008 Q4 | -253.95 Thousand CAD | -110.87% |
| 2008 Q3 | 2.33 Million CAD | 191.35% |
| 2008 Q1 | -362.43 Thousand CAD | -321.18% |
| 2007 FY | - CAD | -59.29% |
| 2007 Q1 | -276.01 Thousand CAD | -6.84% |
| 2007 Q3 | -215.05 Thousand CAD | 86.71% |
| 2007 Q4 | -86.05 Thousand CAD | 59.99% |
| 2007 Q2 | -1.61 Million CAD | -486.2% |
| 2006 Q1 | -129.65 Thousand CAD | 23.97% |
| 2006 Q2 | -340.73 Thousand CAD | -162.81% |
| 2006 Q3 | -667.11 Thousand CAD | -95.78% |
| 2006 Q4 | -258.35 Thousand CAD | 61.27% |
| 2006 FY | - CAD | -72.2% |
| 2005 Q3 | -422.21 Thousand CAD | -400.13% |
| 2005 Q4 | -170.52 Thousand CAD | 59.61% |
| 2005 Q2 | -84.42 Thousand CAD | 78.66% |
| 2005 Q1 | -395.51 Thousand CAD | -997.0% |
| 2005 FY | - CAD | -502.27% |
| 2004 Q4 | -36.05 Thousand CAD | 7.5% |
| 2004 Q1 | -25.6 Thousand CAD | 37.88% |
| 2004 Q3 | -38.97 Thousand CAD | -20.2% |
| 2004 Q2 | -32.42 Thousand CAD | -26.66% |
| 2004 FY | - CAD | -158.75% |
| 2003 Q1 | -31.91 Thousand CAD | 21.16% |
| 2003 FY | - CAD | 236.12% |
| 2003 Q2 | -35.05 Thousand CAD | -9.83% |
| 2003 Q4 | -41.21 Thousand CAD | -6.32% |
| 2003 Q3 | -38.76 Thousand CAD | -10.59% |
| 2002 Q3 | -39.72 Thousand CAD | 13.24% |
| 2002 Q4 | -40.47 Thousand CAD | -1.9% |
| 2002 FY | - CAD | -5.86% |
| 2002 Q1 | -40.09 Thousand CAD | 0.0% |
| 2002 Q2 | -45.78 Thousand CAD | -14.18% |
| 2001 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Avitar, Inc. | -1.66 Million USD | -103.964% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -192.243% |
| Urologix, Inc. | -6.34 Million USD | 46.379% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | -561.78% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | -440.656% |
| CVR Medical Corp. | - USD | Infinity% |
| Össur hf. | 137.38 Million USD | 102.476% |
| Össur hf. | 137.38 Million USD | 102.476% |
| SS Innovations International, Inc. | -20.37 Million USD | 83.305% |
| VMS Rehab Systems, Inc. | -68.55 USD | -4962282.203% |
| QHSLab, Inc. | -91.29 Thousand USD | -3626.149% |
| Bionovate Technologies Corp | - USD | Infinity% |
| BrainsWay Ltd. | -2.31 Million USD | -47.197% |
| BioElectronics Corporation | -274.29 Thousand USD | -1140.188% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 161.607% |
| Theraclion SA | -2.05 Million USD | -65.874% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Positron Corporation | -1.45 Million USD | -134.253% |
| Stratec SE | 39.91 Million USD | 108.523% |
| AVITA Medical, Inc. | -39.56 Million USD | 91.403% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | -2776.494% |
| Zecotek Photonics Inc. | -3.44 Million USD | 1.177% |
| Wellstar International, Inc. | -1.35 Million USD | -150.768% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 134.803% |
| Escalon Medical Corp. | -58.46 Thousand USD | -5718.773% |
| Guided Therapeutics, Inc. | -3.12 Million USD | -8.82% |
| Aurora Spine Corporation | -454.37 Thousand USD | -648.653% |
| NewCardio, Inc. | -9.37 Million USD | 63.732% |
| Vivos Inc. | -2.79 Million USD | -21.788% |
| MicroPort Scientific Corporation | -347.57 Million USD | 99.021% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | -1620.722% |
| REMSleep Holdings, Inc. | -1.66 Million USD | -103.872% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -797.772% |
| Nanomix Corporation | -8.13 Million USD | 58.209% |
| IR-Med Inc. | -4.89 Million USD | 30.464% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | -381.127% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | -97.558% |
| Lombard Medical, Inc. | -28.06 Million USD | 87.88% |
| ALR Technologies Inc. | -6.4 Million USD | 46.851% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 3469.935% |
| Heart Tronics, Inc. | -14.85 Million USD | 77.103% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 74.379% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 62.831% |
| Ingen Technologies, Inc. | -8639.00 USD | -39276.236% |
| United American Healthcare Corporation | -59 Thousand USD | -5665.615% |
| Odyssey Group International, Inc. | -2.13 Million USD | -59.102% |
| ECGI Holdings, Inc. | -2.99 Million USD | -13.753% |
| Polarean Imaging plc | -11.19 Million USD | 69.614% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 845.892% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | -174.473% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | -344.107% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | -1426.678% |
| Smith & Nephew plc | 1 Billion USD | 100.339% |
| NIOX Group Plc | 11.07 Million USD | 130.715% |
| Fuse Medical, Inc. | 1.83 Million USD | 285.348% |
| Broncus Holding Corporation | -25.19 Million USD | 86.501% |
| Brain Scientific Inc. | -7.93 Million USD | 57.123% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 63.777% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | -18387.571% |